Perlmutter Cancer Center at NYU Langone Health retweetledi
Perlmutter Cancer Center at NYU Langone Health
2.4K posts
Perlmutter Cancer Center at NYU Langone Health
@Perlmutter_CC
We combine visionary thinking and compassionate care with the science of treating cancer. An NCI-designated Comprehensive Cancer Center, part of @NYULangone
New York, NY Katılım Ocak 2022
467 Takip Edilen1.6K Takipçiler
Perlmutter Cancer Center at NYU Langone Health retweetledi
We got great ❓from callers that are worth sharing:
🔺Know your family history as it changes your risk of CRC and recs for screening
🔺At age 80, screening is a tailored decision based on risk, health and preferences
🔺Abn imaging ➡️colonoscopy, not stool test
@NYUDocs
Aasma Shaukat MD MPH@AasmaShaukatMD
📻📡Tune in today for a @NYUDocs show where we discuss the expanding pool of CRC screening options including new 💩and 🩸tests! Hosted by the amazing DJ @MarkPochapin and starring guests @peyoungmd and @PascaleWhite1 @NYULH_GastroHep @AmCollegeGastro Tune in!!!👇🏽👇🏽👇🏽👇🏽
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
Last call to register: join us July 24–25, 2026, for the 1st International Symposium on Intra-Tumoral Therapies in Lung Cancer at @nyulangone.
Learn more and register: bit.ly/3RTWdba
#PCCM #LungCancer #MedEd
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
📻📡Tune in today for a @NYUDocs show where we discuss the expanding pool of CRC screening options including new 💩and 🩸tests!
Hosted by the amazing DJ @MarkPochapin and starring guests @peyoungmd and @PascaleWhite1
@NYULH_GastroHep @AmCollegeGastro
Tune in!!!👇🏽👇🏽👇🏽👇🏽
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
Please join us in welcoming Edwin J. Ostrin, MD, PhD, to our Division as Associate Professor of Medicine & Director of OncoPulmonology @nyulangone’s @Pearlmutter_CC
His work focuses on early #lungcancer detection, pulmonary nodules, & biomarkers for cancer risk assessment
#PCCM
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
The future of pancreatic cancer care is biomarker-driven. Kristen Spencer, DO explores how germline testing and somatic alterations are guiding personalized first-line chemotherapy decisions today.
Learn More: hubs.li/Q043CbRd0
@kspencer725 @MSKCC_OncoNotes
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
Excited to share our new paper in @ScienceMagazine A subset of lung cancers drives cachexia, not through factors circulating in the blood, but through local lung sensory neurons. science.org/doi/10.1126/sc… big thanks to first authors Michael and @s_kotschi our collaborators
Cancer Grand Challenges@CancerGrand
What if one of cancer’s most devastating side effects could be reversed? Cancer cachexia is a debilitating wasting syndrome that affects many people with cancer, yet treatment options remain limited. Team CANCAN has published new research in @ScienceMagazine that highlights a previously underappreciated driver of cancer cachexia: localised signals from tumours acting directly on sensory neurons. This is a big step toward reframing cancer cachexia as not only a systemic metabolic condition, but also one shaped by tumour–nerve communication. 🎥 @ThalesPapaG, Co-Investigator on team CANCAN and team InteroCANCEption, explains the discovery and what it could mean for patients. Read the full paper: science.org/doi/10.1126/sc… --- Team CANCAN is funded by @CR_UK and @theNCI through Cancer Grand Challenges.
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
Dr. Daniel R. Gomez, the new chair of Radiation Oncology at NYU Langone's @Perlmutter_CC, shares how molecular profiling is helping identify patients earlier and personalize treatment.
Read the full Q&A ⤵️ bit.ly/3Rc0QNN
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
A sight for sore eyes!
Happy to have @RevMedicines Daraxonrasib available for our patients now under the @US_FDA expanded access program.
Huge thanks to @md_oberstein & @Perlmutter_CC clinical trials office for all the hard work that went into getting this done in record time.
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
Excited to share our study on immune interactions in extramedullary (lung) acute myeloid leukemia (AML) out today at @NatImmunol !! Acute respiratory failure frequently occurs in AML due to leukemia infiltration of the lungs. The question is why and what can we do to suppress it. @VarvaraParask in the lab started this work by mapping AML:stromal and AML:immune cell interactions using scRNA-Seq and Visium/Xenium @10xGenomics spatial tools.
nature.com/articles/s4159…
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
@lustgartenfdn Read more: prnewswire.com/news-releases/…
@DanaFarber | @hopkinskimmel | @MSKCancerCenter | @kochinstitute | @UTMDAnderson | @Perlmutter_CC
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
My @nyulangone @Perlmutter_CC colleague @drsarahruth presenting on older patients with diffuse large B cell #lymphoma @llmcongress Great Debates and Updates meeting
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
#FollowFriday Janice Mehnert, MD, is a medical oncologist and cancer researcher at NYU Langone Health’s Perlmutter Cancer Center, where she specializes in melanoma, skin cancers, early-phase clinical trials and immunotherapy. Outside of medicine, she’s also an incredibly talented musician. 🎶
Follow her today! @JaniceM10 @Perlmutter_CC @nyulangone
English
Well done to our CTO Senior Director, Ankeeta Joshi, who contributed in a national panel on improving clinical trial operations & study activation at #CRI2026!
We’re proud of our expedited clinical trial timelines, making novel treatments more accessible to our patients sooner.
English
Incredible job to our Clinical Trials Office for showcasing impressive strategies to advance cancer research at @AACI_Cancer's #CRI2026 Annual Meeting this week!
See their 11 poster presentations & 3rd-place award-winning abstract: aaci-cancer.org/2026-cri-abstr…
@Aiims1742 @JaniceM10
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
We recently published on dose modification in GI cancer. I think we need to run more trials like ReDOS for all TKIs. I dose escalate these agents. Keeping pts on drug longer + QOL critical in this setting. clinical-colorectal-cancer.com/article/S1533-…
Spencer Lessans@SpenceLessansMD
@TumorBoardTues @CathyEngMD @IntegrityCE 14/24 #TumorBoardTuesday Our patient develops: Grade 2 fatigue Mild diarrhea Grade 1 hypertension Symptoms improve with supportive care + dose modification A reminder: Later-line CRC management is balancing efficacy with maintaining quality of life
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
We are recruiting at @Perlmutter_CC for a myeloma leader of the future!
Reach out to the team… 🙌🏽
@nyugrossman @JohnPLeonardMD
Gareth Morgan@DrGarethMorgan1
Discussing the future of the myeloma program at NYU keen to recruit future leaders if you are interested be in touch we would love to hear from you
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
Next: "Driving Faster and Smarter Study Start-up." Speakers from @Perlmutter_CC @UFHealthCancer & @WinshipatEmory will share practical strategies to improve communication, accelerate study activation & enhance trial efficiency. #CRI2026 #AACICRI #ClinicalResearchInnovation
English
Perlmutter Cancer Center at NYU Langone Health retweetledi
🎙️ @Perlmutter_CC experts @docbraunstein and @AdamKittai recap novel approaches in hematologic cancers presented at #ASCO26 on the latest episode of the #ASCODailyNews Podcast: bit.ly/4vlGNvi
English